Bio-Rad Laboratories | BIO - Ebitda


Bio-Rad Laboratories reported $983.8M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Agilent USD 456M 84M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio Techne USD 116.71M 13.29M Mar/2026
Bio-Rad Laboratories USD 983.8M 1.36B Dec/2025
Bruker USD 110M 101.6M Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Danaher USD 1.92B 204M Mar/2026
General Electric Aerospace USD 2.84B 568M Mar/2026
Illumina USD 469M 137M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Laboratory Of America USD 605.6M 17.5M Mar/2026
Merck USD 6.3B 2.09B Dec/2025
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quest Diagnostics USD 557M 20M Mar/2026
Repligen USD 40.01M 469K Mar/2026
Revvity USD 272.91M 24M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
Siemens EUR 3.56B 80M Mar/2026
Standard Biotools USD -15.81M 734K Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Tosoh JPY 39.13B 286M Dec/2024
Waters USD 380.97M 85.83M Dec/2025